These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


598 related items for PubMed ID: 16002073

  • 1. Effect of praziquantel on the immature stages of Schistosoma haematobium.
    Botros S, Pica-Mattoccia L, William S, El-Lakkani N, Cioli D.
    Int J Parasitol; 2005 Nov; 35(13):1453-7. PubMed ID: 16002073
    [Abstract] [Full Text] [Related]

  • 2. Schistosoma haematobium (Egyptian strain): rate of development and effect of praziquantel treatment.
    Botros SS, Hammam OA, El-Lakkany NM, El-Din SH, Ebeid FA.
    J Parasitol; 2008 Apr; 94(2):386-94. PubMed ID: 18564739
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy of low doses of praziquantel for Schistosoma mansoni and S. haematobium.
    Taylor P, Murare HM, Manomano K.
    J Trop Med Hyg; 1988 Feb; 91(1):13-7. PubMed ID: 3126306
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of praziquantel during the incubation and invasive phase of Schistosoma haematobium schistosomiasis in 18 travelers.
    Grandière-Pérez L, Ansart S, Paris L, Faussart A, Jaureguiberry S, Grivois JP, Klement E, Bricaire F, Danis M, Caumes E.
    Am J Trop Med Hyg; 2006 May; 74(5):814-8. PubMed ID: 16687686
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of praziquantel and reinfection patterns in single and mixed infection foci for intestinal and urogenital schistosomiasis in Cameroon.
    Tchuem Tchuenté LA, Momo SC, Stothard JR, Rollinson D.
    Acta Trop; 2013 Nov; 128(2):275-83. PubMed ID: 23791803
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
    Garba A, Lamine MS, Barkiré N, Djibo A, Sofo B, Gouvras AN, Labbo R, Sebangou H, Webster JP, Fenwick A, Utzinger J.
    Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Failure of standard treatment with praziquantel in two returned travelers with Schistosoma haematobium infection.
    Alonso D, Muñoz J, Gascón J, Valls ME, Corachan M.
    Am J Trop Med Hyg; 2006 Feb; 74(2):342-4. PubMed ID: 16474094
    [Abstract] [Full Text] [Related]

  • 13. Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya.
    Coles GC, Liang YS, Doenhoff MJ.
    Emerg Infect Dis; 2001 Feb; 7(6):1069-70. PubMed ID: 11747748
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inflammation dynamics after praziquantel treatment of Schistosoma haematobium reflected by urinary eosinophil cationic protein.
    Stecher CW, Fofana HKM, Madsen H, Wilson S, Keita AD, Landouré A, Traoré MS, Vennervald BJ, Reimert CM, Sacko M.
    Trans R Soc Trop Med Hyg; 2017 Jul 01; 111(7):316-324. PubMed ID: 29165707
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of single-dose artesunate plus sulfalene/pyrimethamine combined with praziquantel for the treatment of children with Schistosoma mansoni or Schistosoma haematobium in western Kenya: a randomised, open-label controlled trial.
    Obonyo CO, Rawago FO, Makworo NK, Muok EMO.
    Parasit Vectors; 2024 Jun 28; 17(1):279. PubMed ID: 38943214
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Further assessment of Mirazid as antischistosomal drug in experimental schistosomiasis hematobium.
    Ramzy F, Mahmoud S, William S.
    Pharm Biol; 2010 Jul 28; 48(7):775-9. PubMed ID: 20645776
    [Abstract] [Full Text] [Related]

  • 19. Patterns of Schistosoma haematobium infection, impact of praziquantel treatment and re-infection after treatment in a cohort of schoolchildren from rural KwaZulu-Natal/South Africa.
    Saathoff E, Olsen A, Magnussen P, Kvalsvig JD, Becker W, Appleton CC.
    BMC Infect Dis; 2004 Oct 07; 4():40. PubMed ID: 15471549
    [Abstract] [Full Text] [Related]

  • 20. Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study.
    Borrmann S, Szlezák N, Faucher JF, Matsiegui PB, Neubauer R, Binder RK, Lell B, Kremsner PG.
    J Infect Dis; 2001 Nov 15; 184(10):1363-6. PubMed ID: 11679932
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 30.